Abstract
Antidepressants can relief human depression and reduce human depressive symptoms. Nevertheless, some undesired clinical events, such as suicide have been emerging. As for 2004, the US and European regulatory agencies began implementing verification programs to assess the influence on suicidal behavior from the use of antidepressants such as selective serotonin reuptake inhibitors (SSRIs). With the increasing number of reported cases, several newly developed antidepressants were faced with withdrawal from the markets. Despite unclear cause of suicide, researches focusing on revealing the relationship between efficacy and toxicities of antidepressants have been initiated in China and US. To deal with these undesired clinical consequences, new initiatives and revolutionary ideas have been proposed and verified. Hopefully, therapeutic efficacies and outcomes by different types of antidepressant treatments can be improved for clinical trials in future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
